EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A STAT3/integrin axis accelerates pancreatic cancer initiation and progression

Alejandro D Campos, Ryan M Shepard, Zachary Ortega, Ingrid Heumann, Anna E Wilke, Arin Nam, Carson Cable, Kourosh Kouhmareh, Richard Klemke, Nicole M Mattson, Trey Ideker, Camila De Arruda Saldanha und 6 weitere

Cell Reports · 2025-08 · 44 (8) · 116010

DOI: 10.1016/j.celrep.2025.116010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-08. Verfasst von Alejandro D Campos und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Moores Cancer Center at the University of California San Diego, La Jolla, San Diego, CA, USA; Department of Pathology, Sanfo…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Pancreatic Neoplasms, Integrin beta3, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorPancreatic NeoplasmsIntegrin beta3Carcinoma, Pancreatic DuctalHumansCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticSignal TransductionAnimalsMice

Stichwörter der Autor:innen

CP: CancerSTAT3cellular stresscytokineenhancergene signaturehypoxiainflammationintegrinpancreatic cancertumor initiation

Substanzen

STAT3 Transcription FactorIntegrin beta3STAT3 protein, humanITGB3 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Moores Cancer Center at the University of California San Diego, La Jolla, San Diego, CA, USA; Department of Pathology, Sanford Consortium for Regenerative Medicine at the University of Californi…
  • Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.
  • Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA; Departments of Bioengineering and Computer Science and Engineering, University of Ca…
  • School of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.
  • Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California San Francisco, San Francisco, CA, USA.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • University of California, San Diego
  • Tobacco-Related Disease Research Program
  • National Institutes of Health Office of the Director
  • Foundation for the National Institutes of Health
  • National Institutes of Health

Zitieren

APA

Campos, A. D., Shepard, R. M., Ortega, Z., Heumann, I., Wilke, A. E., Nam, A., Cable, C., Kouhmareh, K., Klemke, R., Mattson, N. M., Ideker, T., De Arruda Saldanha, C., Heinz, S., Weaver, V., Von Schalscha, T., Wettersten, H. I., Weis, S. M., & Cheresh, D. A. (2025). A STAT3/integrin axis accelerates pancreatic cancer initiation and progression. Cell Reports, 44(8), 116010. https://doi.org/10.1016/j.celrep.2025.116010

Vancouver

Campos AD, Shepard RM, Ortega Z, Heumann I, Wilke AE, Nam A, et al. A STAT3/integrin axis accelerates pancreatic cancer initiation and progression. Cell Reports. 2025;44(8):116010. doi:10.1016/j.celrep.2025.116010

BibTeX
@article{Campos2025,
  author = {Campos, Alejandro D and Shepard, Ryan M and Ortega, Zachary and Heumann, Ingrid and Wilke, Anna E and Nam, Arin and Cable, Carson and Kouhmareh, Kourosh and Klemke, Richard and Mattson, Nicole M and Ideker, Trey and De Arruda Saldanha, Camila and Heinz, Sven and Weaver, Valerie and Von Schalscha, Tami and Wettersten, Hiromi I and Weis, Sara M and Cheresh, David A},
  title = {A STAT3/integrin axis accelerates pancreatic cancer initiation and progression},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {8},
  pages = {116010},
  doi = {10.1016/j.celrep.2025.116010}
}
Kostenlos starten →